Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
Tags:
EGFR lung cancer, lung cancer, Eli Lilly, Cyramza, AstraZeneca, Tagrisso
FDA approves Pfenex's osteoporosis therapy
Yahoo/Reuters
Mon, 10/7/19 - 10:56 am
Tags:
Pfenex, osteoporosis, PF708, FDA, Eli Lilly, Forteo
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Fri, 10/4/19 - 09:49 am
Tags:
Bayer, Eli Lilly, Humalong, Humulin, diabetes, whistleblower lawsuits
Eli Lilly to voluntarily delist from Euronext Paris exchange
Marketwatch
Thu, 10/3/19 - 10:35 am
Tags:
Eli Lilly, Europe
Mom approved: J&J, Takeda and more lead Working Mother's best places to work list for 2019
Fierce Pharma
Wed, 10/2/19 - 10:53 am
Tags:
JNJ, Takeda, parents, Eli Lilly, Merck, Novo Nordisk, Sanofi
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
Tags:
diabetes, Eli Lilly, Merck, Novo Nordisk, GSK, Byetta, Victoza, Bydureon, Ozempic, Tanzeum, Trulicity, Rybelsus
Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program
Fierce Pharma
Wed, 09/25/19 - 11:30 pm
Tags:
China, Sanofi, AstraZeneca, Eli Lilly, drug pricing
Sigilon Therapeutics approaches the clinic
EP Vantage
Thu, 09/19/19 - 08:11 pm
Tags:
Sigilon, orphan drug, hemophilia A, Eli Lilly, diabetes
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Wed, 09/18/19 - 09:53 am
Tags:
Novo Nordisk, Eli Lilly, oral semaglutide, Trulicity, diabetes
Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed
Drug Channels
Tue, 09/17/19 - 03:35 pm
Tags:
Eli Lilly, Janssen, Merck, Novartis, Sanofi, drug pricing
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Tue, 09/17/19 - 11:00 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, kidney disease, JNJ, EASD
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Tue, 09/17/19 - 10:05 am
Tags:
Novo Nordisk, Eli Lilly, Sanofi, UK, Brexit, insulin, diabetes
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
Sun, 09/15/19 - 09:47 pm
Tags:
breast cancer, FDA, Ibrance, Kisqali, Verzenio, Pfizer, Novartis, Eli Lilly
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Tags:
Novo Nordisk, diabetes, ICER, oral semaglutide, Eli Lilly, Boehringer Ingelheim, Jardiance, Ozempic
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
Tags:
WCLC, lung cancer, KRAS, AMG 510, Amgen, RET, Merck, Keytruda, AstraZeneca, Imfinzi, Blueprint Medicines, Eli Lilly
Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer
Fierce Biotech
Mon, 09/9/19 - 10:21 am
Tags:
Eli Lilly, Loxo Oncology, LOXO-292, non-small cell lung cancer
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Tags:
Amgen, AMG 510, Mirati Therapeutics, MRTX849, Eli Lilly, LOXO-292, Blueprint Me, Pralsetinibdicines
Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share
Fierce Pharma
Thu, 09/5/19 - 10:37 am
Tags:
Amgen, CGRPs, Aimovig, migraines, Eli Lilly, Emgality
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Mon, 09/2/19 - 12:25 pm
Tags:
Eli Lilly, Mylan, Alimta, FDA, generics, lung cancer
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Fri, 08/30/19 - 10:48 am
Tags:
Mylan, Eli Lilly, generics, Alimta, non-squamous non-small cell lung cancer, mesothelioma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.